Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IGKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17RE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY10P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FABP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCLAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MESDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEMD1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on